NYSSA Presents 9th Annual Biotech/Specialty Pharma Conference
Posted on: Tuesday, 29 November 2005, 12:00 CST
The New York Society of Security Analysts (NYSSA) will present the 9th Annual Biotech/Specialty Pharma Conference on December 14 to 15, 2005.
Positive news from drug companies and a strengthening economy have given biotech and specialty pharma stocks a respectable year thus far. What does the future have in store for some of the industry's fastest-growing small cap drug companies? Learn where the investment opportunities are in these developing sectors.
The following companies are presenting on day one:
Advancis Pharmaceutical Corp. (Nasdaq: AVNC); Bionovo, Inc. (OTCBB: NBVI); BioSante Pharmaceuticals, Inc. (AMEX: BPA); Celsion Corporation (AMEX: CLN); Depomed, Inc. (Nasdaq: DEPO); DNAPrint genomics, Inc. (OTCBB: DNAG); DURECT Corporation (Nasdaq: DRRX); Elite Pharmaceuticals, Inc. (AMEX: ELI); Exact Sciences (Nasdaq: EXAS); Matritech, Inc. (Amex: MZT); and Valentis, Inc. (Nasdaq: VLTS).
The following companies are presenting on day two:
Aethlon Medical, Inc. (OTC: AEMD); Bioenvision (Nasdaq: BIVN); Commonwealth Biotechnologies, Inc. (Nasdaq: CBTE); Hemispherx Biopharma, Inc. (AMEX: HEB); NovaDel Pharma Inc. (AMEX: NVD); Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM); SIGA Technologies, Inc. (Nasdaq: SIGA); and Zonagen, Inc. (Nasdaq: ZONA).
The conference will be held on December 14 to 15, 2005, 8:00 a.m. to 5:00 p.m., at the Harvard Club, 27 West 44th Street, New York, NY. Early registration by November 30 one day, $195 NYSSA members, $295 nonmembers; two days, $295 NYSSA members, $395 nonmembers. Prices $70 higher after November 30. Registration deadline is December 7. No charge for press with credentials. A complete agenda is available at http://www.nyssa.org/Template.cfm?Section=calendar&template=/ ContentManagement/ContentDisplay.cfm&ContentID=6289 (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
About NYSSA
NYSSA, established in 1937, is the premier independent forum for the exchange of information among investment decision-makers. A not-for-profit educational organization with over 9,000 members, NYSSA is committed to the promotion of best practices and the highest professional and ethical standards in the investment industry. NYSSA is the largest of the more than 131 societies worldwide that make up CFA Institute, which has more than 70,000 members.
Source: Business Wire
Related Articles
- Leading Companies Increase Their Customer Experience Investment in Tough Economic Times According to Surprising New Study; Strativity Group Reveals Results of Their 2009 Customer Experience Benchmark Study Online
- Interstate Power and Light Company Seeks Cost Recovery for Investments in Electric Reliability and Damages From Recent Natural Disasters
- NGP Capital Resources Company Schedules Release of December 31, 2008 Financial Results, Investor Conference Call for March 12, 2009 and Annual Meeting for May 13, 2009
- Reminder: ER Urgent Care Centers Retains Joeseph Emas to File Registration Statement to Become OTC NASDAQ Bulletin Board Company
- ER Urgent Care Centers Retains Joeseph Emas to File Registration Statement to Become OTC NASDAQ Bulletin Board Company
- XTL Biopharmaceuticals to Present at the NYSSA 10th Annual Biotech/Specialty Pharma Industry Conference
- Cyclacel Pharmaceuticals to Present at NYSSA 10th Annual Biotech/Speciality Pharma Industry Conference
- NovaDel Pharma Inc. To Present at NYSSA's 9th Annual Biotech/Specialty Pharma Investor Conference
- Path 1 Network Technologies Reports Inducement Stock Option Grant Under AMEX Company Guide Section 711(A)
- DNAPrint Genomics Completes Initial Research for Production of Company's First Pharmaceutical Product
 |
 |
User Comments (0)
RSS Feeds